Welcome to Universal Cells, Inc.!
Universal Cells aims to provide our customers with the tools they need to reliably and accurately edit the stem cell genome. Our technology is based on AAV-mediated gene targeting, which offers high accuracy and safety, and the best vehicle available for cellular delivery.
A major focus of Universal Cells is the genetic manipulation of histocompatibility genes in order to create non-immunogenic therapeutic stem cell lines. We have developed proprietary technology that enables the immune evasion of transplantable stem cells by eliminating and/or customizing HLA gene expression, thus allowing researchers and companies to work with a histocompatible, allogeneic, off-the-shelf stem cell product for the regenerative medicine market.